Tevogen Bio Holdings Inc (NASDAQ:TVGN) price is hovering lower on current market day and dropping -12.32% below its previous close.
A look at today’s price movement shows that the recent level at last check reads $1.38, with intraday deals fluctuating between $1.18 and $1.35. The company’s 5Y monthly beta was ticking -1.029. Taking into account the 52-week price action we note that the stock hit a 52-week high of $21.09 and 52-week low of $0.26. The stock added 18.63% on its value in the past month.
Tevogen Bio Holdings Inc, which has a market valuation of $211.81 million, is expected to release its quarterly earnings report in February.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give TVGN a short term outlook of 50% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Buy, while an average of long term indicators are currently assigning the stock as 50% Buy.
The overview shows that TVGN’s price is at present 7.94% off the SMA20 and -7.12% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 50.15, with weekly volatility standing at 20.82%. The indicator jumps to 13.86% when calculated based on the past 30 days. Tevogen Bio Holdings Inc (NASDAQ:TVGN)’s beta value is holding at -1.24, while the average true range (ATR) indicator is currently reading 0.18.
An analysis of the Tevogen Bio Holdings Inc (NASDAQ:TVGN) stock in terms of its daily trading volume indicates that the 3-month average is 16.61 million. However, this figure increases on the past 10-day timeline to an average of 1.84 million.
Current records show that the company has 170.77M in outstanding shares. The insiders’ percentage holdings are 85.76% of outstanding shares while the percentage share held by institutions stands at 3.23%. The stats also highlight that short interest as of 2024-10-31, stood at 3.69 million shares, which puts the short ratio at the time at 0.09. From this we can glean that short interest is 1170.00 of company’s current outstanding shares. Notably, we see that shares short in October rose slightly given the previous month’s figure stood at 0.58 million. But the 17.48% upside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.
